Nyxoah S.A.
NYXH • Medical - Specialties
$1.62
▼ -0.14 (-7.95%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$62.18M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 64.6%Manageable debt level · 0.86Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 12, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.62
Change-7.95%
Market Cap$62.18M
52W Range1.26 - 8.59
Beta0.62
Gross Margin63.13%
Oper. Margin-8.28%
Profit Margin-8.99%
Debt/Eq0.86
Current Ratio1.25
Quick Ratio1.16
Target$5.00
Price$1.62
Change-7.95%
Market Cap$62.18M
52W Range1.26 - 8.59
Beta0.62
Gross Margin63.13%
Oper. Margin-8.28%
Profit Margin-8.99%
Debt/Eq0.86
Current Ratio1.25
Quick Ratio1.16
Target$5.00
Target Upside208.64%
Target Median$5.00
Target Range3.00 - 7.00
Volume100.53K
Avg Volume256.13K
EPS Surprise0.11
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
59/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score▼
Positive revenue growth · 64.6%Manageable debt level · 0.86Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-24
Low
$3.00
Mean
$5.00
Median
$5.00
High
$7.00
🧾
No insider activity
No recent insider transactions available.